603222.SHG Zhejiang Chimin Pharm Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
7.10 CNY
Close of Nov 4, 2026
6.52 12.36
Market cap
CNY 3.73B
P/E
-
P/B
3.36x
ROE
-10.4%
Dividend yield
0.53%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603222.SHG undervalued?

Graham number

The Graham number of Zhejiang Chimin Pharm Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Zhejiang Chimin Pharm Co Ltd fundamental analysis

No fundamental analysis for Zhejiang Chimin Pharm Co Ltd yet.

Zhejiang Chimin Pharm Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Zhejiang Chimin Pharm Co Ltd

Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells in vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-pipe double-valve, single-pipe single-valve, and single-pipe double-valve soft bags; plastic bottles; and other packaging forms. It also offers injection puncture medical devices, including safety syringes, safety injection needles, sterile syr…

Full company profile